<DOC>
	<DOCNO>NCT02525172</DOCNO>
	<brief_summary>The purpose study ass anti-recombinant human acid α-glucosidase ( anti-rhGAA ) antibody titer treatment immune modulation therapy patient Pompe disease .</brief_summary>
	<brief_title>Immune Modulation Therapy Pompe Disease</brief_title>
	<detailed_description />
	<mesh_term>Glycogen Storage Disease Type II</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Bortezomib</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>The patient ( and/or patient 's legal guardian patient &lt; 18years ) must provide write informed consent prior studyrelated procedure perform ; The patient must confirm diagnosis Pompe disease define documented acid αglucosidase ( GAA ) enzyme deficiency blood sample 2 GAA gene mutation ; The patient ( and/or legal guardian ) must ability comply clinical protocol ; Regimen A : The patient receive enzyme replacement therapy , exhibit clinical decline , persistent high antirecombinant human acid αglucosidase ( antirhGAA ) antibody titer and/or test positive antibody inhibit enzymatic activity and/or uptake Myozyme ; Regimen B : The patient crossreactive immune material ( CRIM ) negative AND receive Myozyme infusion prior enrollment The patient risk reactivation carrier Hepatitis B Hepatitis C ; The patient risk reactivation tuberculosis regular contact individual actively treat tuberculosis ; The patient use investigational product ( alglucosidase alfa ) within 30 day prior study enrollment ; The patient pregnant lactating ; The patient require live vaccination within one month prior enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>immune modulation therapy</keyword>
	<keyword>acid α-glucosidase</keyword>
	<keyword>antibody</keyword>
</DOC>